Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October 2013 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2013 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Microembolic signal monitoring of TOAST‑classified cerebral infarction patients

  • Authors:
    • Jiandong Jiang
    • Yulong Jiang
    • Shouqin Feng
    • Dejin Sun
    • Aixia Zhuang
    • Qinghong Zeng
    • Yi Zhang
    • Hongmei Huang
    • Hongxia Nie
    • Fang Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Neurological Examination, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Radiology, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Ultrasound, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China
  • Pages: 1135-1142
    |
    Published online on: August 1, 2013
       https://doi.org/10.3892/mmr.2013.1609
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the effects of microembolic signals (MES) on post‑stroke neurological deficits, stroke recurrence and survival in patients with acute cerebral infarction (CI). Patients with acute CI were enrolled consecutively and classified etiologically into the following 4 subtypes using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification: i) Cardioembolism (CE); ii) large‑artery atherosclerosis (LA); iii) small‑vessel disease (SVD); and iv) stroke of other etiology, including other and undetermined etiologies. The MES of cerebral arteries were monitored by transcranial doppler (TCD), carotid atherosclerotic lesions were detected by color Doppler sonography and extracranial and intracranial magnetic resonance angiography were performed. Next, the severity of neurological deficits was evaluated using National Institutes of Health Stroke Scale (NIHSS) scores. Cases of stroke recurrence and post‑stroke mortality were recorded. A total of 135 patients were recruited, including 33 with CE, 49 with LA, 24 with SVD and 29 with stroke of other etiology. A significant difference in the incidence of MES was identified between the 4 subtypes (P=0.025). The occurrence of positive MES was found to markedly correlate with a history of coronary heart disease (P<0.001) and antithrombotic treatment (P=0.045) and increased levels low density lipoprotein (P=0.036). Compared with patients with negative MES, no significant changes in NIHSS scores were found in patients with positive MES on days 1 and 7 following admission. The incidence of recurrent stoke and post‑stroke mortality was elevated 3 months from the onset of CI. In conclusion, a significant difference in the occurrence of MES was identified between subtypes of patients with acute CI. The incidence of recurrent stroke and mortality was increased among patients with positive MES 3 months from onset.
View Figures
View References

1 

Spencer MP, Thomas GI, Nicholls SC, et al: Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 21:415–423. 1990. View Article : Google Scholar

2 

No authors listed. Basic identification criteria of Doppler microembolic signals. Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. Stroke. 26:11231995. View Article : Google Scholar

3 

Grosset DG, Georgiadis D, Kelman AW, et al: Detection of microemboli by transcranial Doppler ultrasound. Tex Heart Inst J. 23:289–292. 1996.PubMed/NCBI

4 

Al-Mubarak N, Roubin GS, Vitek JJ, et al: Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 104:1999–2002. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Droste DW, Junker K, Hansberg T, et al: Circulating microemboli in 33 patients with intracranial arterial stenosis. Cerebrovasc Dis. 13:26–30. 2002. View Article : Google Scholar : PubMed/NCBI

6 

Gao S, Wong KS, Hansberg T, et al: Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke. 35:2832–2836. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Sliwka U, Lingnau A, Stohlmann WD, et al: Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study. Stroke. 28:358–363. 1997. View Article : Google Scholar : PubMed/NCBI

8 

Wong KS, Gao S, Chan YL, et al: Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol. 52:74–81. 2002. View Article : Google Scholar

9 

Kimura K, Minematsu K, Koga M, et al: Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke. AJNR Am J Neuroradiol. 22:1037–1042. 2001.PubMed/NCBI

10 

Nakajima M, Kimura K, Shimode A, et al: Microembolic signals within 24 hours of stroke onset and diffusion-weighted MRI abnormalities. Cerebrovasc Dis. 23:282–288. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Markus HS and MacKinnon A: Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke. 36:971–975. 2005. View Article : Google Scholar

12 

Iguchi Y, Kimura K, Kobayashi K, Yamashita S, Shibazaki K and Inoue T: Microembolic signals after 7 days but not within 24 hours of stroke onset should be predictor of stroke recurrence. J Neurol Sci. 263:54–58. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Valton L, Larrue V, le Traon AP, et al: Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke. 29:2125–2128. 1998. View Article : Google Scholar : PubMed/NCBI

14 

DeGraba TJ, Hallenbeck JM, Pettigrew KD, et al: Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke. 30:1208–1212. 1999. View Article : Google Scholar : PubMed/NCBI

15 

Hao WH, Leung KS, Wong, et al: The significance of microembolic signals and new cerebral infarcts on the progression of neurological deficit in acute stroke patients with large artery stenosis. Cerebrovasc Dis. 29:424–430. 2010. View Article : Google Scholar

16 

Markus HS and Brown MM: Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model. Stroke. 24:1–5. 1993.

17 

Junghans U and Siebler M: Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 107:2717–2721. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Adams HP, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24:35–41. 1993. View Article : Google Scholar : PubMed/NCBI

19 

Goldstein LB, Jones MR, Matchar DB, et al: Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 32:1091–1098. 2001. View Article : Google Scholar

20 

Nabavi DG, Arato S, Droste DW, et al: Microembolic load in asymptomatic patients with cardiac aneurysm, severe ventricular dysfunction and atrial fibrillation. Clinical and hemorheological correlates. Cerebrovasc Dis. 8:214–221. 1998. View Article : Google Scholar

21 

Kumral E, Balkir K, Uzuner N, et al: Microembolic signal detection in patients with symptomatic and asymptomatic lone atrial fibrillation. Cerebrovasc Dis. 12:192–196. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Goertler M, Blaser T, Krueger S, et al: Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry. 72:338–342. 2002. View Article : Google Scholar

23 

Junghans U and Siebler M: Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 107:2717–2721. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Delcker A, Schnell A and Wilhelm H: Microembolic signals and clinical outcome in patients with acute stroke - a prospective study. Eur Arch Psychiatry Clin Neurosci. 250:1–5. 2000. View Article : Google Scholar : PubMed/NCBI

25 

Goertler M, Baeumer M, Kross R, et al: Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke. 30:66–69. 1999. View Article : Google Scholar : PubMed/NCBI

26 

Lund C, Rygh J, Stensrød B, et al: Cerebral microembolus detection in an unselected acute ischemic stroke population. Cerebrovasc Dis. 10:403–408. 2000. View Article : Google Scholar : PubMed/NCBI

27 

Abbott AL, Chambers BR, Stork JL, et al: Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke. 36:1128–1133. 2005. View Article : Google Scholar

28 

Iosif C, Oppenheim C, Lamy C, et al: Bilateral hypoperfusion and normal diffusion MR images in a case of acute embolic stroke. Cerebrovasc Dis. 26:95–96. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Schlaug G, Benfield A, Baird AE, et al: The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 53:1528–1537. 1999. View Article : Google Scholar : PubMed/NCBI

30 

Iguchi Y, Kimura K, Kobayashi K, et al: Microembolic signals at 48 hours after stroke onset contribute to new ischaemia within a week. J Neurol Neurosurg Psychiatry. 79:253–259. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Kang DW, Kwon SU, Yoo SH, et al: Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis. Arch Neurol. 64:50–54. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiang J, Jiang Y, Feng S, Sun D, Zhuang A, Zeng Q, Zhang Y, Huang H, Nie H, Zhou F, Zhou F, et al: Microembolic signal monitoring of TOAST‑classified cerebral infarction patients. Mol Med Rep 8: 1135-1142, 2013.
APA
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q. ... Zhou, F. (2013). Microembolic signal monitoring of TOAST‑classified cerebral infarction patients. Molecular Medicine Reports, 8, 1135-1142. https://doi.org/10.3892/mmr.2013.1609
MLA
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q., Zhang, Y., Huang, H., Nie, H., Zhou, F."Microembolic signal monitoring of TOAST‑classified cerebral infarction patients". Molecular Medicine Reports 8.4 (2013): 1135-1142.
Chicago
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q., Zhang, Y., Huang, H., Nie, H., Zhou, F."Microembolic signal monitoring of TOAST‑classified cerebral infarction patients". Molecular Medicine Reports 8, no. 4 (2013): 1135-1142. https://doi.org/10.3892/mmr.2013.1609
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang J, Jiang Y, Feng S, Sun D, Zhuang A, Zeng Q, Zhang Y, Huang H, Nie H, Zhou F, Zhou F, et al: Microembolic signal monitoring of TOAST‑classified cerebral infarction patients. Mol Med Rep 8: 1135-1142, 2013.
APA
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q. ... Zhou, F. (2013). Microembolic signal monitoring of TOAST‑classified cerebral infarction patients. Molecular Medicine Reports, 8, 1135-1142. https://doi.org/10.3892/mmr.2013.1609
MLA
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q., Zhang, Y., Huang, H., Nie, H., Zhou, F."Microembolic signal monitoring of TOAST‑classified cerebral infarction patients". Molecular Medicine Reports 8.4 (2013): 1135-1142.
Chicago
Jiang, J., Jiang, Y., Feng, S., Sun, D., Zhuang, A., Zeng, Q., Zhang, Y., Huang, H., Nie, H., Zhou, F."Microembolic signal monitoring of TOAST‑classified cerebral infarction patients". Molecular Medicine Reports 8, no. 4 (2013): 1135-1142. https://doi.org/10.3892/mmr.2013.1609
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team